Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial by KROPFF, Martin, GIONGCO BAYLON, Honorata, AVET-LOISEAU, Herve, MOEHLER, Thomas M, PATTOU, Claire, LUCY, Lela, KUEENBURG, Elisabeth, GLASMACHER, Axel, ZERBIB, Robert, FACON, Thierry, HILLENGASS, Jens, ROBAK, Tadeusz, HAJEK, Roman, LIEBISCH, Peter, GORANOV, Stefan, HULIN, Cyrille, BLADE, Joan, CARAVITA, Tommaso

Get full text

Treatment (Tx) With Pomalidomide (POM) and Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI) Including... by Sonneveld, P, Dimopoulos, M, Ramasamy, K, Kueenburg, E, Rosettani, B, Collins, S, Bacon, P, Weisel, K.C

Get full text

A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide by Gamberi, Barbara, Berthou, Christian, Hernandez, Miguel, Semenzato, Gianpietro, Tholouli, Eleni, Hájek, Roman, Caers, Jo, Dimopoulos, Meletios, Minnema, Monique C., Andreasson, Bjorn, Parreira, Joana, Crotty, Gerard, Remes, Kari, Kueenburg, Elisabeth, Rosettani, Barbara, Di Micco, Antonia, Peters, Sarah, Bacon, Pamela, Blau, Igor Wolfgang

Get full text

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function by Li, Yan, Wang, Xiaomin, O'Mara, Edward, Dimopoulos, Meletios A, Sonneveld, Pieter, Weisel, Katja C, Matous, Jeffrey, Siegel, David S, Shah, Jatin J, Kueenburg, Elisabeth, Sternas, Lars, Cavanaugh, Chloe, Zaki, Mohamed, Palmisano, Maria, Zhou, Simon

Get full text

PS1420 RESULTS FROM A POST‐AUTHORIZATION SAFETY STUDY COMPARING LENALIDOMIDE‐BASED WITH NON–LENALIDOMIDE‐BASED TREATMENT IN TRANSPLANT‐INELIGIBILE NEWLY DIAGNOSED MULTIPLE MYELOMA... by De Stefano, V., Cavo, M., Payer, A. Ramirez, Bilgin, Y., Wiesholzer, M., Ziske, C., Kueenburg, E., Di Micco, A., Rosettani, B., Pozzi, S., Bacon, P., Gamberi, B.

Request full text

PS1418 POMALIDOMIDE‐BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WHO DIED IN THE EUROPEAN POST APPRO... by Gamberi, B., Abildgaard, N., Payer, A. Ramirez, Kyriakou, C., Hieber, M. Schmidt, Di Raimondo, F., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba‐Davies, M., Bacon, P., Plesner, T.

Request full text

PB2117 POMALIDOMIDE PLUS LOW‐DEXAMETHASONE TREATMENT FOR ≥ 1 YEAR IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A SUBANALYSIS OF THE MM‐013 PHASE 2 ST... by Weisel, K., Dimopoulos, M., Cook, M., Ramasamy, K., La Rubia, J., Ardizzoia, A., Krauth, M. T., Jaccard, A., Van de Donk, N., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba‐Davies, M., Bacon, P., Sonneveld, P.

Request full text

Metabolic Effects of Isradipine Versus Hydrochlorothiazide in Diabetes Mellitus by Klauser, Renate, Prager, Rudolf, Gaube, Susanne, Gisinger, Christoph, Schnack, Christoph, Kiienburg, Elisabeth, Schernthaner, Guntram

Get full text